|
angiotensin_2
|
S1456-p
|
|
BI2536
|
S1030-p
,
S1260-p
,
S2229-p
|
|
dasatinib
|
S1456-p
|
|
EGF
|
S1456-p
|
|
ischemia
|
S523-p
,
S650-p
,
S805-p
,
S1312-p
,
S1456-p
,
T1469-p
,
S1522-p
|
|
LRRK2-IN-1
|
S1040-p
,
S1456-p
|
|
metastatic potential
|
S1456-p
|
|
metformin
|
S1040-p
,
S1260-p
,
S1714-p
|
|
MLN8054
|
S88-p
,
S92-p
,
S1260-p
,
S1456-p
,
S2232-p
|
|
nocodazole
|
S805-p
,
S809-p
,
S1019-p
,
S1260-p
,
T1310-p
,
S1312-p
,
S1456-p
,
S1522-p
,
S1974-p
|
|
SB202190
|
S1456-p
|
|
selumetinib
|
S1456-p
|
|
SII_angiotensin_2
|
S1456-p
,
S1714-p
|
|
U0126
|
S1456-p
|
|
vemurafenib
|
S1456-p
|